During the past decade, Spartanburg Medical Research conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 30 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spartanburg Medical Research" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Pearl Therapeutics, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Sucampo Pharma Americas, LLC" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spartanburg Medical Research" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "Sucampo AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Spartanburg Medical Research" are "Chronic Obstructive Pulmonary Disease" (15 trials), "Asthma" (8 trials), "COPD" (6 trials), "Influenza" (6 trials) and "Pulmonary Disease, Chronic Obstructive" (5 trials). Many other conditions were trialed in "Spartanburg Medical Research" in a lesser frequency.

Most popular intervention types in "Spartanburg Medical Research" are "Drug" (60 trials), "Biological" (11 trials), "Other" (5 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Inhaled Placebo" (3 trials), "Lubiprostone" (3 trials), "Salmeterol" (3 trials) and "Tiotropium" (3 trials). Other intervention names were less common.

The vast majority of trials in "Spartanburg Medical Research" are 73 trials for "All" genders.

Currently, there are NaN active trials in "Spartanburg Medical Research". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Spartanburg Medical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Spartanburg Medical Research, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".